GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Origin Therapeutics Holdings Inc (XCNQ:ORIG) » Definitions » Net Issuance of Debt

Origin Therapeutics Holdings (XCNQ:ORIG) Net Issuance of Debt : C$0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Origin Therapeutics Holdings's net issuance of debt for the three months ended in Jun. 2023 was C$0.00 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Jun. 2023 was C$0.00 Mil.


Origin Therapeutics Holdings Net Issuance of Debt Historical Data

The historical data trend for Origin Therapeutics Holdings's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Net Issuance of Debt Chart

Origin Therapeutics Holdings Annual Data
Trend Sep21 Sep22
Net Issuance of Debt
- -

Origin Therapeutics Holdings Quarterly Data
Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only - - - - -

Origin Therapeutics Holdings Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Origin Therapeutics Holdings Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Origin Therapeutics Holdings (XCNQ:ORIG) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
505 Burrard Street, Suite 1570, Vancouver, BC, CAN, V7X 1M5
Origin Therapeutics Holdings Inc is an investment company focusing on investments in the psychedelic industry.

Origin Therapeutics Holdings (XCNQ:ORIG) Headlines

From GuruFocus

Paul Singer's 6 Largest New Holdings

By Sydnee Gatewood Sydnee Gatewood 11-28-2017

Ocean Rig UDW Inc. Announces Updates to Rig Employment

By Marketwired Marketwired 07-23-2018

Strong Results Makes Ocean Rig Attractive

By Faisal Humayun Faisal Humayun 11-10-2014

Bullish Developments Continue For Ocean Rig

By Faisal Humayun Faisal Humayun 06-30-2014

Ocean Rig: Growth And Dividends To Continue

By Faisal Humayun Faisal Humayun 05-11-2014